Ex Vivo Stimulation of Whole Blood as a Means to Determine Glucocorticoid Sensitivity to Mild-to-Moderate and Refractory Asthmatics

Stopped early

Conditions studied: Asthma

In brief

Gluococorticoids are commonly prescribed to treat a number of diseases including the majority of inflammatory diseases. Despite considerable inter-personal variability in responses to glucocorticoids between asthmatics, an insensitivity rate of about 30% and the risk of adverse side effects of glucocorticoid therapy, no assay is currently performed to determine sensitivity in severe and non-severe asthmatics prior to treatment. The purpose of this study is to perform a whole blood ex vivo stimulation assay to interrogate known glucocorticoid receptor (GR) up- and down-regulated genes to indicate glucocorticoid sensitivity and compare the results between severe and non-severe asthmatics.

Key facts

Study ID

NCT01698983

Run by

Jeanette Marketon, MD

People needed

14

Starts

2011-06-01

Expected to finish

2012-10-01

Last updated by the study team

2012-10-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• To be eligible for the study, subjects must meet all of the following criteria:
• Age ≥ 18 years old
• Physician diagnosis of asthma confirmed through medical record documentation.
• Documented history of 12% FEV1 reversibility post-bronchodilator and/or Methacholine PC 20 score of 16mg/ml or less.
• Non-smoker for > 6 months before enrollment into the trial
• Less than 5 pack year smoking history defined as the average packs smoked per day multiplied by the years of active smoking.
• Willing and able to adhere to the study visit schedule and other protocol-specified procedures.

You may not qualify if…

• Subjects meeting any of the following criteria may not be enrolled in the study:
• Existence of lung disease (other than asthma)
• Recent asthma exacerbation requiring hospital admissions, unexpected healthcare visits, or prednisone courses in the previous 4 weeks.
• Non-English speaking.
• Participation in another interventional research trial
• Self-reported pregnancy
• Inability or unwillingness to provide consent
• Febrile illness (>38.0˚ C or 100.4˚ F) within 24 hours of visit.

Where it is running

• Martha Morehouse Medical Pavillion — Columbus, Ohio, United States
• Martha Morehouse Medical Pavillion — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.